These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2509171)

  • 1. ABO haemolytic disease: sex ratio and blood groups in the newborns requiring treatment.
    Hodr R
    Czech Med; 1989; 12(3):125-33. PubMed ID: 2509171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO hemolytic disease: a comparative study of clinical severity and delayed anemia.
    Kanto WP; Marino B; Godwin AS; Bunyapen C
    Pediatrics; 1978 Sep; 62(3):365-9. PubMed ID: 568235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototherapy for ABO haemolytic hyperbilirubinaemia.
    Tan KL; Lim GC; Boey KW
    Biol Neonate; 1992; 61(6):358-65. PubMed ID: 1525269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ABO incompatibility and newborn haemolytic disease: two cases with major erythroblastosis].
    Palleau S; Le Tourneau C; Jrad I; Andreux JP; Gouin I; Siguret V
    Ann Biol Clin (Paris); 2004; 62(3):344-8. PubMed ID: 15217770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
    Fischer K; Poschmann A; Grundmann A
    Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phototherapy for hyperbilirubinemia of hemolytic disease of the newborn.
    Maurer HM; Kirkpatrick BV; McWilliams NB; Draper DA; Bryla DA
    Pediatrics; 1985 Feb; 75(2 Pt 2):407-12. PubMed ID: 4038554
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
    Hodr R; Vondrácek J; Skutilová J
    Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
    [No Abstract]   [Full Text] [Related]  

  • 14. Haemocarboperfusion treatment of neonatal haemolytic jaundice.
    Marosvári I; Köves S
    Acta Paediatr Acad Sci Hung; 1980; 21(2-3):81-4. PubMed ID: 7193398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Septicemia in children treated with exchange transfusions because of hemolytic disease of the newborn].
    Kordyasz E
    Pediatr Pol; 1995 Sep; 70(9):733-7. PubMed ID: 8657505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maternal blood group 0 as a risk factor of neonatal hyperbilirubinemia requiring treatment].
    Heier HE; Fugelseth D; Lindemann R; Qvigstad E
    Tidsskr Nor Laegeforen; 1996 Jan; 116(1):34-6. PubMed ID: 8553332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of different blood components on exchange transfusion outcomes.
    Ghaemi S; Saneian H; Mo'ayedi B; Pourazar A
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S45-8. PubMed ID: 22768458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemolytic anaemia in the newborn infant.
    Walker W
    Clin Haematol; 1975 Feb; 4(1):145-66. PubMed ID: 810288
    [No Abstract]   [Full Text] [Related]  

  • 20. Jaundice: a 10 year review of 41,000 live born infants.
    Palmer DC; Drew JH
    Aust Paediatr J; 1983 Jun; 19(2):86-9. PubMed ID: 6414449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.